What Is TMS Therapy for Depression?

Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation therapy for major depressive disorder. An electromagnetic coil placed on the scalp delivers repeated magnetic pulses to the left dorsolateral prefrontal cortex — a region involved in mood regulation. The magnetic field passes through the skull and induces small electrical currents in the cortex, increasing activity in an area that is often underactive in depression.

TMS devices are FDA-cleared for adults with major depressive disorder who have not improved enough on antidepressant medication in their current episode. The first device, NeuroStar, was cleared in October 2008. TMS is one of several depression treatment options and is not the same as electroconvulsive therapy (ECT).

Depression is associated with reduced activity in the left dorsolateral prefrontal cortex, a brain region involved in mood regulation. TMS uses a focused magnetic field — similar in strength to an MRI — to stimulate this area. The magnetic pulses pass through the scalp and skull and induce small electrical currents in the cortex, which are thought to increase activity in the targeted region and its connected mood circuits.

Unlike medication, which affects the whole body through the bloodstream, TMS targets a specific brain region. Unlike ECT, TMS does not induce a seizure or require anesthesia. The stimulation is delivered while you sit awake in a chair, and you can return to normal activities immediately afterward.

FDA-cleared TMS is intended for adults with major depressive disorder who have not achieved satisfactory improvement from prior antidepressant medication in the current episode. A psychiatrist evaluates factors such as diagnosis, medication history, and overall health before recommending treatment.

Eligibility also depends on safety screening. People with ferromagnetic metal in or near the head, implanted electronic devices, or certain seizure histories may not be candidates. TMS is generally not used during a manic episode. Because every situation is different, candidacy is determined by a qualified healthcare provider — not by a web page.

During a TMS session you sit in a reclined chair while a technician positions an electromagnetic coil against your scalp, usually over the left prefrontal cortex. You remain fully awake and alert. You will hear clicking sounds and feel a tapping or knocking sensation on your scalp as the magnetic pulses are delivered.

Hearing protection is worn because the coil is loud. The first session includes motor threshold mapping — finding the magnetic intensity that causes a small thumb twitch — so the treatment dose is tailored to you. After the session ends you can get up, drive yourself home, and return to work or normal activities right away.

A standard FDA-cleared course is about 30 to 36 sessions, delivered five days a week for roughly four to six weeks. Each session lasts from about 3 minutes with intermittent theta burst stimulation (iTBS) to about 40 minutes with older 10 Hz protocols. Including setup and positioning, a typical visit takes about 15 to 45 minutes depending on the protocol.

Accelerated protocols such as SAINT® deliver multiple sessions per day over a shorter overall period — five consecutive days instead of six weeks. Your psychiatrist recommends a protocol based on your situation and your insurance plan's criteria. See our overview of what a typical TMS treatment course looks like.

For many people whose depression has not responded to medication, TMS can reduce symptom severity and, in some cases, lead to remission. Because TMS is non-invasive and does not require anesthesia, it can be delivered in an outpatient setting with no driving restriction or recovery time. Many patients continue their daily routines — including work — throughout a standard course.

TMS may also be an option for people who cannot tolerate certain antidepressant side effects. However, benefits are not guaranteed and vary from person to person. A realistic treatment plan sets measurable goals and a reassessment date.

The most commonly reported side effects are scalp discomfort or pain at the treatment site, headache, and facial muscle twitching during stimulation. These usually lessen over the first week as you adjust to the sensation. Over-the-counter pain relievers and small adjustments to coil position or intensity help most patients.

The most serious known risk is seizure, which is rare — estimated at under 0.1% of sessions with standard parameters and proper screening. Hearing protection is worn because the coil is loud. Rarely, TMS can trigger manic symptoms in people with bipolar disorder, which is why mood history is screened before treatment.

TMS is not appropriate for everyone. People with ferromagnetic metal in or near the head (such as cochlear implants or aneurysm clips), implanted electronic stimulators, or a history of seizures require careful evaluation and may not be candidates. Tell your treatment team about any implants, seizure history, or medication changes.

Clinical studies have reported that TMS can reduce depression symptoms in many adults whose depression has not responded to medication, though it does not work for everyone. In a 301-person randomized sham-controlled trial, active TMS was superior to sham. In a 307-patient real-world naturalistic study, researchers observed about 58% response and 37% remission on clinician-rated scales.

These figures describe groups, not individuals. Roughly 40% or more of patients in real-world series do not meet response criteria, and some who improve later relapse. The naturalistic study had no control group. Individual results vary, and no treatment guarantees remission. Discuss your own likelihood of benefit with a psychiatrist.

The THREE-D trial (414 patients) found intermittent theta burst stimulation (iTBS) non-inferior to standard 10 Hz TMS, supporting shorter 3-minute sessions as an equivalent once-daily option.

Antidepressant medication affects the whole body through the bloodstream and works over weeks as brain chemistry adjusts. TMS targets a specific brain region with magnetic pulses and does not involve drugs. For many patients, TMS is considered when antidepressants have not produced adequate improvement.

TMS and medication are not mutually exclusive — many people continue an antidepressant during TMS. The two can be combined, and a psychiatrist determines the best approach. Learn more about depression and its treatment options or about treatment-resistant depression.

Traditional TMS delivers one session a day, five days a week, for about four to six weeks. Accelerated TMS delivers multiple sessions per day, compressing the course into a shorter period. Neither is universally better — each has different schedules, settings, and eligibility considerations.

The comparison below summarizes the general differences. Individual protocols vary by clinic and device. Only the SAINT® protocol has its own FDA clearance as an accelerated treatment; most other accelerated schedules are off-label uses of FDA-cleared devices. See our guide to accelerated TMS and theta burst stimulation for more detail.

Asking the right questions helps you understand whether TMS is appropriate for you and what to expect. Consider asking your provider:

• Which TMS device do you use, and what is it FDA-cleared for?
• How many sessions will I need, and how long is each one?
• What are the common side effects, and how are they managed?
• How will my response be measured during and after treatment?
• What is the plan if I do not improve?